Nitric oxide synthase and postischemic liver injury

S Kawachi1, I N Hines, F S Laroux

  • 1Department of Molecular and Cellular Physiology, LSU Health Sciences Center, Shreveport, Louisiana, 71130, USA.

Insights

Endothelial nitric oxide synthase (eNOS) protects against liver injury caused by ischemia and reperfusion (I/R). Mice lacking eNOS showed worse liver damage, while those lacking inducible nitric oxide synthase (iNOS) did not.

Area of Science:

  • Physiology
  • Immunology
  • Hepatology

Background:

  • Ischemia and reperfusion (I/R) injury is a significant clinical problem.
  • Nitric oxide synthase (NOS) isoforms, endothelial (eNOS) and inducible (iNOS), are implicated in I/R injury.
  • The specific roles of eNOS and iNOS in liver I/R injury remain unclear.

Purpose of the Study:

  • To investigate the roles of eNOS and iNOS in I/R-induced liver injury in vivo.
  • To compare liver injury severity in eNOS-deficient and iNOS-deficient mice.

Main Methods:

  • Induction of partial liver ischemia (70%) for 45 minutes followed by 5 hours of reperfusion in wild-type (wt), eNOS-deficient, and iNOS-deficient mice.
  • Assessment of liver injury by measuring serum alanine aminotransferase (ALT) levels.
  • Histopathological examination and myeloperoxidase (MPO) determination to assess neutrophil infiltration.

Main Results:

  • Significant liver injury, indicated by elevated ALT, occurred in wt mice after I/R.
  • No significant neutrophil infiltration was observed in the liver at the assessed time point.
  • eNOS-deficient mice exhibited significantly enhanced liver injury compared to wt mice.
  • iNOS-deficient mice showed no significant difference in liver injury compared to wt mice.

Conclusions:

  • Endothelial nitric oxide synthase (eNOS)-derived nitric oxide (NO) plays a protective role in limiting liver I/R injury.
  • Inducible nitric oxide synthase (iNOS)-derived NO does not appear to play a significant role in this model of liver I/R injury.
  • Targeting eNOS may offer a therapeutic strategy for mitigating liver I/R injury.